Fact-checked by Grok 2 weeks ago

Palsy

Palsy is a medical term, derived from Old French and Latin roots meaning paralysis, denoting partial or complete loss of muscle control due to nervous system disruption, often accompanied by weakness, tremors, or involuntary movements in affected body parts. It can result from various causes and affect people of any age, leading to symptoms like muscle weakness, sensory loss, and uncoordinated movements. The term is commonly used in compounds to describe specific neurological disorders, such as (a non-progressive from early , affecting about 1 in 345 children in the United States as of recent estimates), (temporary facial paralysis), (a rare neurodegenerative condition), and (neonatal arm weakness). Detailed causes, symptoms, diagnosis, and management vary by type and are covered in subsequent sections; many forms lack a cure but can be managed with therapies and supportive care.

Overview

Definition

Palsy is a medical term used to describe a condition characterized by partial or complete , involving , loss of voluntary muscle control, or impaired movement in a specific body part, typically resulting from damage or dysfunction of innervating those muscles. This impairment arises due to disruptions in the , leading to an inability to initiate or sustain muscle contractions as intended. Historically, the term "palsy" originated in the from the Latin paralysis, derived from the Greek parálusis meaning "loosening" or "disabling," and was broadly applied to various forms of motor dysfunction observed in ancient medical texts and biblical references to -like states. In contemporary medical usage, palsy functions primarily as a symptom or clinical sign within a range of neurological disorders rather than a distinct disease entity, often specifying the affected area or underlying , as seen in conditions like or . Palsy differs from related terms such as , which denotes only partial with some retained voluntary control, and , which signifies a total loss of motor function in the affected area without any movement capability. While palsy may encompass both partial and complete losses, it is sometimes associated with additional features like tremors, distinguishing it in certain contexts from pure .

Classification

Palsy is classified in multiple ways to facilitate understanding and management, primarily based on anatomical location, temporal characteristics, and functional impact on . These categorizations help distinguish between different underlying mechanisms and guide clinical approaches, though overlaps can occur in complex cases.

Anatomical Classification

Palsies are broadly divided into central and peripheral types depending on the site of neurological involvement. Central palsy arises from lesions or dysfunction in the or , leading to deficits that often manifest as increased and . In contrast, peripheral palsy involves damage to the peripheral , , or muscles themselves, resulting in signs such as flaccid weakness and . This distinction is crucial for determining the scope of neurological impairment, with central forms typically affecting broader motor pathways while peripheral ones are more localized.

Temporal Classification

The onset and duration of palsy provide another key framework for categorization. Congenital palsy is present at birth, often due to prenatal developmental issues or genetic factors, and may persist lifelong without . Acquired palsy develops postnatally from events like , , or vascular incidents. Additionally, palsies can be transient, resolving spontaneously or with treatment as in some cases of , or permanent, where deficits endure despite therapy. Temporal aspects influence and strategies, with congenital forms requiring early to optimize outcomes.

Functional Classification

Functionally, palsies are delineated by muscle tone abnormalities, aiding in the assessment of . Flaccid palsy is characterized by reduced (), leading to limpness, diminished reflexes, and potential fasciculations due to . palsy, conversely, involves heightened (), with velocity-dependent resistance to passive movement, exaggerated reflexes, and clasp-knife phenomenon, often stemming from lesions. exemplifies a central, congenital palsy, highlighting how functional traits intersect with other classifications. This dichotomy informs therapeutic targets, such as antispasticity agents for forms versus supportive care for flaccid ones.

Causes and Pathophysiology

Neurological Mechanisms

Palsy arises from disruptions in the neural pathways that control voluntary muscle movement, primarily involving lesions to upper motor neurons (UMNs) or lower motor neurons (LMNs). UMNs originate in the cerebral cortex and descend through tracts like the corticospinal pathway to influence LMNs in the spinal cord or brainstem, modulating muscle tone and coordination. Lesions in UMNs, such as those affecting the descending motor tracts, result in spasticity—a velocity-dependent increase in muscle tone—along with hyperreflexia and weakness, but without significant muscle atrophy initially, as the LMNs remain intact to innervate muscles. In contrast, LMN lesions, which occur at the anterior horn cells, nerve roots, or peripheral nerves, lead to flaccid paralysis, hypotonia, hyporeflexia, muscle atrophy, and fasciculations due to direct denervation of muscle fibers. These distinctions highlight how the site of disruption determines the pattern of motor impairment, with UMN lesions preserving reflex arcs while LMN lesions abolish them. Pathophysiological processes underlying these disruptions often include demyelination, axonal damage, and , which impair the transmission of neural signals to muscles. Demyelination involves the loss or damage to the sheath surrounding , disrupting and leading to slowed or blocked action potentials, particularly in peripheral nerves or central tracts. Axonal damage, whether from , ischemia, or degeneration, causes the axon to fragment and undergo distal to the injury site, resulting in permanent loss of signal propagation if regeneration fails. contributes by triggering immune responses that target neural components, causing edema, infiltration of inflammatory cells, and secondary damage to or axons, thereby exacerbating conduction failures. These processes collectively reduce the efficiency of motor signal delivery, manifesting as the weakness or characteristic of palsy. The role of neurotransmitters and synaptic failures further elucidates the loss of muscle control in palsy. In UMN lesions, damage disrupts descending inhibitory pathways, leading to an imbalance where excitatory neurotransmitters like glutamate dominate over inhibitory ones such as and , resulting in hyperexcitability and due to unopposed alpha activity. Synaptic failures at central levels, including reduced inhibitory synaptic transmission, amplify this imbalance by failing to dampen firing rates. For LMN lesions, synaptic dysfunction often occurs at the , where impaired release of —the primary excitatory —or receptor desensitization prevents effective muscle , leading to flaccid weakness and from . These disruptions and synaptic inefficiencies underscore the breakdown in precise neural-muscle communication central to palsy's .

Risk Factors

Risk factors for palsy encompass a range of environmental, perinatal, and genetic elements that can predispose individuals to congenital or acquired forms of the condition. For congenital palsies, such as , prenatal factors including maternal infections during pregnancy significantly elevate the risk, as pathogens can disrupt fetal brain development. Similarly, perinatal complications like premature birth and —defined as less than 2.5 kilograms—increase susceptibility, with preterm infants facing heightened vulnerability due to immature neural structures. Birth , characterized by oxygen deprivation during delivery, further compounds this risk by potentially leading to brain injury in newborns. Acquired palsies often arise from post-developmental insults, including trauma such as or head injuries, which can damage neural pathways and result in motor impairments. Infections like , caused by , are notable triggers, particularly for facial palsy, as the pathogen invades the and induces cranial nerve dysfunction. Exposure to toxins, including such as lead or mercury, also poses a risk, with environmental contamination linked to neurodegenerative changes that may manifest as progressive forms of palsy. Genetic predispositions contribute to palsy through mutations in genes critical for neural development, accounting for an estimated 10-30% of cerebral palsy cases. These include variants in neuritogenesis genes, which regulate neuron growth and connectivity, thereby increasing vulnerability when combined with environmental stressors. Such mutations highlight the interplay between hereditary factors and external risks in the etiology of palsy.

Specific Conditions

Cerebral Palsy

Cerebral palsy (CP) is a group of permanent movement disorders that appear in early childhood, resulting from non-progressive disruptions in the developing brain that affect muscle control, posture, and coordination. It is classified as a central palsy due to its origin in the central nervous system, distinguishing it from peripheral types. The condition arises from brain injuries occurring prenatally (before birth, accounting for 75-80% of cases), perinatally (around birth, less than 10%), or postnatally (after birth), with the timing influencing the predominant motor subtype. Subtypes include spastic CP (70-80% of cases), characterized by stiff muscles and exaggerated reflexes; dyskinetic CP (10-20%), involving involuntary writhing or jerky movements; and ataxic CP (5-10%), marked by poor balance and coordination; mixed forms combine these features. Primary brain lesions associated with CP include periventricular leukomalacia (PVL), a injury near the brain's ventricles common in premature infants, and hypoxic-ischemic encephalopathy (HIE), caused by oxygen deprivation and reduced blood flow during the perinatal period. PVL often leads to , while HIE frequently results in more widespread damage affecting multiple brain regions. These lesions disrupt neural pathways essential for motor function, with prenatal causes linked to infections or vascular issues, perinatal to birth complications, and postnatal to infections or . CP has lifelong effects on voluntary , maintaining , and fine motor coordination, often requiring assistive devices for in moderate to severe cases. Comorbidities are prevalent, with intellectual disabilities affecting 30-50% of individuals (e.g., 48% cognitive difficulties in large cohorts) and sensory impairments including visual issues in 30-54% and in about 8%. These associated conditions, such as or communication challenges, further impact but vary by lesion severity and location.

Bell's Palsy

Bell's palsy is an acute, idiopathic condition characterized by sudden onset of unilateral facial weakness or paralysis resulting from inflammation or compression of the seventh cranial nerve, also known as the . This typically affects the muscles of on one side, leading to drooping of the , inability to close the eye, and flattening of the , without involvement of the if the lesion is proximal. It is classified as a disorder within the peripheral category of facial palsies. The condition is often associated with viral triggers, particularly reactivation of latent herpes simplex virus type 1 (HSV-1) in the , which may cause and ischemia. Other potential contributors include herpes zoster or immune-mediated responses, though the exact remains idiopathic in most cases. Symptoms usually develop over 48 to 72 hours, peaking within the first week, and may include , altered taste, or pain around the ear. The annual incidence of Bell's palsy is estimated at 20 to 30 cases per 100,000 people, affecting individuals of all ages but most commonly those between 15 and 60 years. Approximately 70% to 85% of patients experience spontaneous recovery of facial function within three to six months, often beginning within three weeks of onset. In cases of incomplete recovery, which occur in 15% to 30% of patients, chronic complications such as —aberrant regeneration leading to involuntary muscle contractions, like eye closure during smiling—can develop due to misdirected nerve regrowth. Other sequelae include persistent , facial spasms, or crocodile tears syndrome, impacting quality of life and necessitating targeted therapies.

Other Forms

Erb's palsy, also known as Erb-Duchenne palsy, is a form of primarily affecting the upper trunk (C5-C6 nerve roots), resulting in and weakness in the arm, often presenting as the "waiter's tip" posture due to birth trauma from excessive lateral traction on the fetal neck during delivery. This peripheral accounts for approximately 60% of birth palsies and leads to impaired and external of the , with the typically pronated. Klumpke's palsy, in contrast, involves the lower (C8-T1 roots) and causes of the intrinsic hand muscles and flexors of the wrist and fingers, often from hyperabduction traction during birth or arm extension injuries, resulting in a "claw hand" deformity and potential Horner syndrome if sympathetic fibers are affected. Todd's palsy represents a example, characterized by transient postictal weakness or hemiplegia following a , typically lasting from minutes to 36 hours (with a mean of about 15 hours) due to neuronal exhaustion or temporary inhibition in the affected brain region. This condition, which may occur after the first or recurrent episodes, usually resolves completely without residual deficits, distinguishing it from through its epileptic context and reversibility. , a variant of motor neuron disease akin to , involves progressive degeneration of lower s in the , leading to weakness in muscles controlling , speech, and , with initial symptoms like and . Progressive supranuclear palsy (PSP) is a rare, progressive neurodegenerative disorder leading to difficulties with balance, eye movements, and swallowing, primarily affecting those over 60. In systemic diseases, can manifest with palsies through demyelination of central pathways, often presenting as isolated cranial nerve weaknesses such as abducens (sixth nerve) palsy causing horizontal or involvement in about 0.2% of cases, differentiated by its relapsing-remitting nature and association with other multifocal symptoms like . Guillain-Barré syndrome, an acute , frequently includes bilateral facial palsy in 20-60% of cases alongside ascending limb weakness and paralysis, triggered post-infection and marked by rapid progression, areflexia, and elevated protein without pleocytosis as key features.

Symptoms and Signs

Motor Impairments

Motor impairments in palsy represent the core physical deficits arising from disruptions in neural pathways controlling voluntary movement, often stemming from damage to upper or lower motor neurons. These impairments manifest as abnormalities in , coordination, and voluntary control, leading to reduced mobility and functional limitations. In conditions like , motor deficits are classified into spastic ( with stiffness), dyskinetic (involuntary movements such as or tremors), and ataxic (impaired and coordination) types, each affecting the precision and smoothness of actions. Bell's palsy, by contrast, typically involves acute unilateral facial muscle weakness or paralysis due to lower motor neuron involvement, resulting in drooping of the or inability to close the eye on the affected side. Such impairments frequently arise from underlying neural lesions in the or peripheral nerves, altering signal transmission to muscles. These motor deficits profoundly influence daily activities, compromising , fine motor skills, and . For instance, or can cause difficulties in walking, leading to scissoring gait in (affecting both lower limbs) or asymmetrical limping in hemiplegia (one-sided involvement), which hinders independent ambulation and increases fall risk. Fine motor challenges, such as tremors or , impair grasping objects or performing precise tasks like buttoning clothes, while facial palsy may disrupt swallowing or articulation, contributing to or slurred speech. In broader terms, these limitations extend to and mobility, with examples like quadriplegia in severe cases restricting all limb function and requiring assistive devices for basic activities. In other forms, such as , motor impairments include progressive difficulty with balance, walking, and eye movements like vertical gaze palsy; manifests as weakness and paralysis of the arm due to . Progression patterns in palsy vary by etiology, distinguishing static from progressive forms. Cerebral palsy exemplifies a static condition, where the initial brain injury does not worsen, though secondary musculoskeletal changes like contractures may evolve over time, altering motor function without advancing the neural damage itself. In contrast, progressive palsies, such as those in certain neurodegenerative disorders, involve ongoing deterioration of motor control, with worsening weakness or over years. Bell's palsy often follows an acute, non-progressive course, with most cases showing of motor function within months.

Associated Features

Individuals with palsy often experience a range of secondary sensory disturbances beyond primary motor deficits. In cerebral palsy, sensory processing issues can manifest as hypersensitivity or hyposensitivity to stimuli such as touch, temperature, or texture, leading to discomfort or numbness in affected areas. Vision and hearing impairments are also prevalent, with 75-90% of children with cerebral palsy exhibiting some degree of visual dysfunction, including strabismus or cortical visual impairment, while hearing loss affects approximately 14% of cases. In peripheral forms like Bell's palsy, neuropathic pain or altered facial sensation, such as tingling or burning around the ear or jaw, arises from inflammation of the facial nerve. These sensory symptoms can exacerbate daily functioning challenges by interfering with environmental awareness and comfort. Cognitive and emotional features frequently accompany palsy, contributing to a broader impact on . Approximately 50% of individuals with have co-occurring or learning disabilities, which may involve difficulties with , , or executive function. Emotional effects, such as and anxiety, are elevated in this population, with adults with facing approximately 1.3 to 1.4 times the risk compared to the general population, often linked to chronic disability and . Fatigue is another common emotional and physical correlate, reported in 34% of adults with spastic bilateral alongside , stemming from sustained energy demands of impaired mobility and pain. Systemic effects of palsy can lead to secondary orthopedic and gastrointestinal complications due to underlying and imbalance. Orthopedic deformities, particularly , develop in 20-25% of individuals with overall, rising to 74% among non-ambulatory patients, as asymmetrical promotes spinal curvature. Gastrointestinal issues, including , gastroesophageal , and delayed gastric emptying (), affect up to 80% of those with severe , resulting from weakened abdominal and muscles that impair and sphincter control. These features highlight the multisystem nature of palsy, necessitating integrated management approaches.

Diagnosis

Clinical Assessment

The clinical assessment of palsy begins with a detailed to elucidate the underlying and guide further evaluation. Key elements include the timing of onset, which can distinguish acute events like vascular insults from gradual progression seen in degenerative conditions; a history of , such as or peripheral nerve damage, which may point to traumatic causes; family history to identify potential genetic factors, as in hereditary neuropathies; and the progression of symptoms, noting any exacerbating factors like fatigue or infection. This history helps contextualize symptoms, such as unilateral weakness, which may suggest focal pathology. Physical examination focuses on targeted neurological testing to quantify impairments. is assessed using scales like the Modified Ashworth Scale, which grades from 0 (no increase in tone) to 4 (affected part rigid in flexion or extension), particularly relevant in lesions. Reflex assessment involves testing deep tendon reflexes, where may indicate central involvement or suggest peripheral issues, using standardized techniques like the knee-jerk response. Coordination is evaluated through tests such as finger-to-nose or heel-to-shin maneuvers to detect or , aiding in localizing the . Differential diagnosis requires systematically ruling out mimics through history and exam findings. For instance, acute unilateral facial palsy might suggest if accompanied by other focal deficits, whereas fluctuating with ptosis could indicate . Conditions like Guillain-Barré syndrome are considered if ascends symmetrically post-infection, emphasizing the need to exclude life-threatening etiologies early. This process ensures accurate classification of palsy as central, peripheral, or functional.

Imaging and Tests

Diagnosis of palsy often involves a range of imaging and laboratory tests to identify underlying causes, such as structural abnormalities, damage, infections, or genetic factors, thereby confirming the and assessing the extent of involvement. These objective tests complement clinical evaluation by providing measurable evidence of neurological impairment. Selection of specific modalities is guided by initial clinical findings, such as the pattern of motor deficits or history of . Neuroimaging plays a central role in evaluating central causes of palsy. (MRI) is the preferred modality for detecting brain lesions associated with , as it reveals detailed structural changes like or cortical malformations without radiation exposure. In cases of acute potentially leading to palsy, computed (CT) scans are utilized for rapid assessment of hemorrhages or fractures, though MRI is favored for follow-up due to superior resolution. For peripheral palsies, (EMG) and nerve conduction studies (NCS) are essential to evaluate muscle and nerve function, measuring electrical activity to localize sites of damage and distinguish between axonal and demyelinating processes. Blood tests are routinely employed to rule out infectious or metabolic contributors to palsy. In suspected cases of , serologic testing for , such as enzyme-linked immunosorbent assay () followed by confirmation, helps identify infection as a mimic or cause. Similarly, panels for metabolic disorders, including or levels, can uncover treatable etiologies like or electrolyte imbalances that may present with palsylike symptoms. Specialized procedures further refine diagnosis for specific subtypes. , involving analysis, is indicated for inflammatory causes of palsy, such as in suspected Guillain-Barré syndrome or , where elevated protein levels or pleocytosis indicate immune-mediated nerve root involvement. For hereditary forms, through targeted panels or whole-exome sequencing identifies mutations in genes like those associated with or certain variants, aiding in familial counseling and precise classification.

Management and Treatment

Medical Interventions

Medical interventions for palsy primarily target underlying causes such as , viral infection, or , with treatments varying by type including and . For , often linked to viral reactivation, oral corticosteroids like (typically 60-80 mg daily for 5-10 days) are recommended as first-line therapy to reduce swelling and improve recovery rates, ideally initiated within 72 hours of symptom onset. Antiviral agents, such as acyclovir (400 mg five times daily for 7-10 days) or valacyclovir (1 g three times daily for 7 days), are frequently combined with corticosteroids, particularly in severe cases, to address potential involvement, though evidence shows only modest additional benefit in functional recovery. In , where arises from damage, type A (Botox) injections into affected muscles provide targeted relief by temporarily blocking release, reducing for 3-6 months and facilitating better motor function. Surgical procedures are reserved for cases unresponsive to medications or involving structural issues. In Bell's palsy with incomplete recovery after 3-6 months, facial nerve decompression surgery may be considered to relieve pressure on the nerve within the temporal bone, though it remains controversial due to risks like hearing loss and limited evidence of superior outcomes over conservative management. For cerebral palsy, tendon transfer surgeries reposition muscles or tendons to counteract contractures and improve limb positioning; for instance, transferring the flexor carpi ulnaris to the extensor side enhances wrist extension and hand function in upper extremity involvement. In severe dystonic cerebral palsy, deep brain stimulation via implanted electrodes in the globus pallidus or superior cerebellar peduncle modulates abnormal neural activity, leading to sustained reductions in dystonia severity and improved quality of life in select patients. For peripheral nerve palsies like those in brachial plexus injuries (e.g., Erb's palsy), nerve decompression or tendon transfers restore motor function by alleviating compression or rerouting viable tendons. Emerging therapies as of 2025 focus on regenerative approaches to address neurological deficits at their source. Stem cell transplantation, particularly mesenchymal stromal cells from umbilical cord blood, has shown safety and efficacy in clinical trials for cerebral palsy, with meta-analyses indicating improvements in gross motor function and cognitive scores compared to controls, though long-term data are still accruing. Gene therapy trials remain nascent for palsy-related conditions, primarily targeting genetic subtypes like hereditary spastic paraplegia through viral vector delivery to correct mutations, but no large-scale approvals exist yet for broader palsy applications. These interventions may complement symptom management for pain but do not replace rehabilitative approaches.

Rehabilitative Therapies

Rehabilitative therapies play a crucial role in managing palsy by focusing on improving motor , independence, and overall through non-pharmacological interventions tailored to the individual's needs. These therapies aim to enhance strength, coordination, and adaptive skills while addressing limitations caused by , , or impaired mobility common in conditions like . A multidisciplinary team, including physical therapists, occupational therapists, and speech-language pathologists, collaborates to create personalized programs that promote functional gains without altering the underlying neurological . Physical therapy emphasizes exercises to build strength, flexibility, , and motor , often incorporating , strengthening routines, and to improve . For children with , targeted interventions such as and goal-directed functional have shown moderate evidence of effectiveness in enhancing upper recovery and overall parameters, including stride length and walking speed. Occupational therapy complements this by focusing on fine motor skills and daily living activities, using adaptive equipment like specialized utensils or writing aids to foster independence in tasks such as dressing and eating. aids, including walkers or wheelchairs, are commonly prescribed to support safe and prevent secondary complications like contractures. Speech and swallowing therapy is essential for patients with bulbar involvement, where weakness in the muscles of the mouth, throat, and face leads to or . Therapists employ strengthening exercises, such as effortful swallowing and oral motor drills, to improve articulation and safe food intake, reducing risks like . (AAC) devices, ranging from low-tech picture boards to high-tech eye-tracking systems or speech-generating apps, enable effective expression for those with severe speech impairments, particularly in or . These tools, including dedicated tablets or apps like those from Dynavox, facilitate participation in social and educational settings by allowing users to select symbols or words that are converted to speech. Multidisciplinary approaches integrate , , and psychological support to optimize outcomes across physical, functional, and emotional domains. Ankle-foot orthoses (AFOs) are widely used in to stabilize the foot and ankle during , improving efficiency by controlling equinus deformity and enhancing knee and ankle . leverages water's buoyancy and resistance for low-impact exercises that reduce , boost muscle strength, and promote balance, with studies showing benefits in gross motor function and daily living skills over extended periods. Psychological support, including or peer counseling, addresses emotional challenges like anxiety or , which are prevalent in palsy patients, thereby enhancing adherence to and overall .

Prognosis and Complications

Long-Term Outcomes

Long-term outcomes for palsy vary significantly depending on the type and severity of the condition. In , an acute peripheral disorder, the majority of individuals achieve substantial recovery. Approximately 71% of patients experience complete recovery of facial muscle function, with rates reaching 83.3% after two years of follow-up, particularly among those with partial at onset who recover at higher rates (up to 94%) compared to those with complete (around 61%). In contrast, , a permanent affecting movement and posture, typically requires lifelong management, as the underlying does not resolve, necessitating ongoing multidisciplinary support to optimize function and . For other forms, prognosis differs markedly. (PSP) is a degenerative condition with a median survival of 6 to 9 years after symptom onset, often leading to severe in balance, eye movements, and swallowing. , typically resulting from birth trauma, shows good recovery in most cases, with over 90% of infants regaining full arm function through , though severe cases may require surgical intervention. Several key factors influence these outcomes across palsy types. Early plays a ; for instance, in , initiating therapies before six months of age has been shown to enhance motor function and prevent secondary complications, with greater service intensity correlating to improved functional gains. Severity at onset is another major determinant, as higher initial House-Brackmann grades in and greater motor impairment in predict poorer recovery prospects and increased need for long-term accommodations. Access to care further modulates results, with barriers such as and service availability leading to delayed interventions and suboptimal outcomes, while equitable access improves satisfaction and long-term navigation of care needs. Life expectancy also differs markedly. For isolated , survival aligns with the general population once recovery occurs, given its typically self-limited nature without systemic sequelae. In , outcomes range from near-normal lifespan in mild cases—where nearly 99% reach age 20 and survival beyond age 58 is comparable to peers—to reduced expectancy in severe forms, such as quadriplegia with comorbidities, where a two-year-old may have only a 40% chance of reaching age 20 due to associated health challenges. Overall, hinges on tailored management, with early and comprehensive care mitigating functional limitations and enhancing independence.

Potential Complications

Individuals with palsy, particularly , face significant physical complications arising from chronic , , and immobility. Contractures, which involve the shortening and stiffening of muscles and tendons, commonly develop due to prolonged , leading to joint deformities and restricted movement. Pressure sores, also known as pressure ulcers, occur frequently in those with limited mobility, as sustained pressure on over bony areas impairs circulation and tissue integrity. Respiratory issues, such as , stem from affecting and mechanics, increasing the risk of inhaling food or secretions into the lungs. Neurologically, chronic pain syndromes represent a major complication, affecting 50% to 75% of individuals and manifesting as nociceptive, neuropathic, or due to musculoskeletal strain, , or nerve involvement. In progressive forms of palsy, such as those associated with certain neurodegenerative conditions mimicking or co-occurring with motor impairments, secondary neurodegeneration may exacerbate motor decline through ongoing neuronal loss in connected brain regions. These neurological risks can intensify over time without intervention, contributing to and reduced functional capacity. Psychosocial complications further compound the challenges of living with palsy, often leading to as mobility and communication limitations hinder participation in community activities and relationships. Individuals with palsy experience at rates 3-4 times higher than in the general . barriers are prevalent, with physical and cognitive impairments restricting job opportunities and workplace accommodations, resulting in higher unemployment rates among affected adults. Caregiver burden is substantial, encompassing emotional and disrupted due to the demands of . Early rehabilitative therapies can help mitigate these risks by improving and reducing .

Epidemiology and History

Prevalence and Demographics

Palsy encompasses a range of neurological conditions characterized by or , with and being among the most common types. Globally, affects an estimated 18 million people of all ages, with an incidence of approximately 2 to 3 cases per 1,000 live births, though rates vary by region and have shown a decline in high-income countries to about 1.6 per 1,000 live births due to advancements in perinatal care. Bell's palsy, a form of temporary facial , has a worldwide annual incidence of 15 to 30 cases per 100,000 people, affecting approximately 0.02% of the population each year. Demographic patterns reveal disparities influenced by socioeconomic and geographic factors. exhibits a slight predominance, with a male-to-female ratio of about 1.4:1, and higher prevalence in low- and middle-income countries due to elevated perinatal risks such as and limited access to healthcare. In these regions, the condition is more common among children from lower-income households and rural areas, where neonatal complications are more frequent. shows no significant bias and peaks in incidence among individuals aged 15 to 45, with equal distribution across socioeconomic groups but potential associations with comorbidities like in certain populations. Recent trends indicate declining rates of in high-income settings, with a 40% reduction over the past 15 years attributed to improved neonatal intensive care and reduced complications, as of 2025 data showing sustained decreases to 1.5 per 1,000 live births in some areas. For infectious-related palsies, including some cases of linked to viral triggers, vaccination programs have contributed to lower incidence by preventing underlying infections, though direct causal links remain under study in 2025 epidemiological reports. Overall, global efforts in coverage, reaching 89% of infants for key vaccines in , indirectly support these trends by mitigating post-infectious neurological risks.

Historical Context

The term "palsy," derived from the parálusis meaning "loosening" or "disabling," entered medical lexicon through Latin paralysis and paralisie, reflecting early understandings of sudden loss of muscle control or . Ancient medical texts provide the earliest descriptions of conditions akin to palsy, particularly those involving sudden onset of weakness or . Around 400 BCE, and the introduced the term "" to describe a sudden cerebrovascular event leading to or full-body , often fatal, which they attributed to an overflow of or blood into the ventricles, causing compression and loss of function. This concept encompassed what modern medicine recognizes as stroke-related palsy, emphasizing symptoms like sudden numbness, speech impairment, and unilateral weakness, with noting its prevalence in middle age and potential for recovery if persisted. Earlier Homeric references around 800 BCE alluded to divine "strikes" causing similar paralytic effects, but Hippocratic writings formalized apoplexy as a natural, rather than supernatural, affliction observable through clinical prognosis. In the , advancements in led to more precise classifications of specific palsies, distinguishing them from broader apoplectic syndromes. English surgeon William John Little, drawing from his 1840s observations of affected children, formalized the term "" in his 1861 publication On the Influence of Abnormal Parturition, Difficult Labours, Premature Birth, and Neonatorum on the Mental and Physical Powers of the Child, describing it as a non-progressive stemming from perinatal , often linked to birth . Concurrently, Scottish anatomist Sir Charles Bell's 1821 work on anatomy identified idiopathic unilateral facial paralysis—now known as —as a distinct , separate from central causes like ; by mid-century, clinicians increasingly recognized its idiopathic nature, with spontaneous recovery in many cases, though earlier descriptions dated to the . These milestones shifted focus from humoral theories to anatomical and perinatal etiologies, laying groundwork for palsy as a spectrum of disorders rather than singular events. The 20th and 21st centuries brought diagnostic and etiological breakthroughs, enhancing through and . (MRI), introduced clinically in the late 1970s and refined in the 1980s, revolutionized palsy assessment by visualizing brain lesions non-invasively; early applications in the 1980s demonstrated its utility in detecting inflammation in and periventricular damage in , surpassing scans in sensitivity for subtle abnormalities. Post-2000 genetic research revealed hereditary components in up to 25-30% of cases previously deemed acquired, with the first confirmed (in the ) identified in 2004, followed by discoveries such as the KANK1 deletion in 2005, and variants in genes like CTNNB1 and AP4 complexes disrupting neuronal migration and connectivity. These findings, supported by whole-genome sequencing studies from the onward, expanded palsy classifications to include monogenic forms, challenging the dominance of environmental causes and prompting integrated diagnostic approaches.

References

  1. [1]
    Paralysis: What It Is, Causes, Symptoms, Management & Types
    Paralysis makes you unable to move certain parts of your body. It occurs when nerve signals can't get through to your muscles.
  2. [2]
    Cerebral Palsy | National Institute of Neurological Disorders and ...
    Mar 20, 2025 · Cerebral palsy (CP) is a brain disorder that appears in infancy or early childhood and permanently affects body movement and muscle coordination.
  3. [3]
    About Cerebral Palsy - CDC
    Jul 23, 2025 · There are four main types of CP: · Spastic cerebral palsy · Dyskinetic cerebral palsy · Ataxic cerebral palsy · Mixed cerebral palsy.
  4. [4]
    Bell's Palsy | National Institute of Neurological Disorders and Stroke
    Apr 7, 2025 · Bell's palsy is a neurological disorder that causes paralysis or weakness on one side of the face.
  5. [5]
    Progressive Supranuclear Palsy (PSP)
    Apr 7, 2025 · Progressive supranuclear palsy (PSP) is a rare neurological disorder that affects body movements, walking and balance, and eye movements.
  6. [6]
    Facial nerve palsy due to birth trauma - MedlinePlus
    Jun 13, 2024 · Facial nerve palsy due to birth trauma is the loss of controllable (voluntary) muscle movement in an infant's face due to pressure on the facial nerve.
  7. [7]
    Medical Definition of Palsy - RxList
    Palsy: Paralysis, generally partial, whereby a local body area is incapable of voluntary movement. For example, Bell's palsy is localized paralysis of the ...
  8. [8]
    PALSY | definition in the Cambridge English Dictionary
    a disease in which there is a loss or reduction of movement in a part of the body as a result of a problem with the brain or nerves.
  9. [9]
    PALSY Definition & Meaning - Merriam-Webster
    1. paralysis; used chiefly in combination oculomotor palsy; see bell's palsy, cerebral palsy. 2. a condition that is marked by uncontrollable tremor and ...Shaking palsy · Bell's palsy · Cerebral Palsy · Palsy-walsy
  10. [10]
    Paresis: Types, Causes, Symptoms, and Treatment - Healthline
    Jan 17, 2020 · Paresis is a condition in which muscle movement is weakened. Unlike paralysis, individuals with paresis still have some control over the affected muscles.
  11. [11]
    The management of peripheral facial nerve palsy: "paresis" versus ...
    Whereas the term "palsy" includes both entities, the term "paralysis" should only be used to describe total loss of nerve function. Patients with incomplete ...
  12. [12]
    Neuroanatomy, Motor Neuron - StatPearls - NCBI Bookshelf
    Jul 24, 2023 · Upper and lower motor neuron lesions cause very different clinical findings. An upper motor neuron lesion is a lesion anywhere from the ...
  13. [13]
    Neuroanatomy, Lower Motor Neuron Lesion - StatPearls - NCBI - NIH
    Unlike UMNs, LMN lesions present with muscle atrophy, fasciculations (muscle twitching), decreased reflexes, decreased tone, negative Babinsky sign, and flaccid ...
  14. [14]
    Motor Neurone - Physiopedia
    Upper motor neuron lesion are lesions anywhere from the cortex to the descending tracts. This lesion causes hyperreflexia, spasticity, and a positive Babinski ...Classes of Motor Neurones · Upper Motor Neurone · Lower Motor Neurone
  15. [15]
    Upper Motor Neuron - an overview | ScienceDirect Topics
    Lesions of upper motor neurons often affect groups of muscles, whereas lesions of lower motor neurons can affect single muscles. Lesions of upper motor neurons ...
  16. [16]
    Spasticity Mechanisms – for the Clinician - PMC - PubMed Central
    Spasticity is a common phenomenon seen in neurologic disorders that result in loss of mobility and may produce pain due to muscle spasms.
  17. [17]
    Excitation-inhibition imbalance in the motor control network - Frontiers
    Spasticity is a representative sign of excessive muscle activity in UMN syndrome, while other signs of excessive muscle activity include the Babinski sign, ...
  18. [18]
    The Neuromuscular Junction in Health and Disease - Frontiers
    This review covers the molecular mechanisms underlying the development and homeostasis of the NMJ and their contribution to health and disease.Missing: palsy | Show results with:palsy
  19. [19]
    What are the risk factors for cerebral palsy? | NICHD
    May 11, 2021 · Low birth weight or preterm birth. · Multiple gestations. · Infertility treatments. · Infections during pregnancy. · Fever during pregnancy. · Blood ...
  20. [20]
    Risk Factors for Cerebral Palsy - CDC
    Oct 4, 2017 · Medical conditions of the mother: Mothers with thyroid problems, intellectual disability, or seizures have a slightly higher risk of having a ...
  21. [21]
    Prenatal and perinatal factors in the etiology of cerebral palsy
    Perinatal risk factors were delayed crying as a measure of birth asphyxia and abnormal delivery. Children who had seizures within 48 hours of birth were at high ...
  22. [22]
    Clinical Care and Treatment of Neurologic Lyme Disease - CDC
    Mar 5, 2025 · Neurological complications most often occur in early disseminated Lyme disease, with numbness, pain, weakness, facial palsy/droop (paralysis of the facial ...
  23. [23]
    Heavy metals contaminating the environment of a progressive ... - NIH
    Jan 17, 2020 · Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured ...
  24. [24]
    Genetic or Other Causation Should Not Change the Clinical ... - NIH
    Accumulating evidence shows that a potential genetic etiology can be identified in between 10% and 30% of individuals with cerebral palsy, because of both de ...<|control11|><|separator|>
  25. [25]
    About 14% of cerebral palsy cases may be tied to brain wiring genes
    Sep 28, 2020 · Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics, September 29, 2020
  26. [26]
    Insights From Genetic Studies of Cerebral Palsy - PMC
    Recent studies have implicated genetic factors as contributors or causes of CP, including single nucleotide variants (SNVs) and genomic copy number variants ( ...
  27. [27]
  28. [28]
    Classification of Cerebral Palsy - Physiopedia
    There are 3 major types of Cerebral Palsy: Spastic (70-80%), Dyskinetic (10-20%) and Ataxic (5-10%); or a combination of the three can occur. Some children ...
  29. [29]
    Cerebral Palsy - StatPearls - NCBI Bookshelf
    Feb 24, 2024 · Cerebral palsy is a group of permanent disorders affecting the development of movement and causing a limitation of activity.
  30. [30]
    Progress in Periventricular Leukomalacia - PMC - PubMed Central
    Periventricular leukomalacia is the predominant form of brain injury underlying this neurologic morbidity and is the most common cause of cerebral palsy in ...
  31. [31]
    Other comorbidities in cerebral palsy - NCBI - NIH
    Moderate-quality evidence from 1 study with 3,884 patients found that the prevalence of cognitive difficulties in children with cerebral palsy was 48%. Low- ...
  32. [32]
    Bell Palsy - StatPearls - NCBI Bookshelf
    Oct 6, 2024 · ... Bell palsy is the most common paralysis of the seventh cranial nerve, accounting for 38% to 83% of cases of facial weakness (see Image. Sir ...
  33. [33]
    Bell's palsy - Symptoms and causes - Mayo Clinic
    Mar 15, 2024 · Bell's palsy is a condition that causes sudden weakness in the muscles on one side of the face. Often the weakness is short-term and improves over weeks.
  34. [34]
    Bell Palsy: Rapid Evidence Review - AAFP
    Patients with Bell palsy should be treated with oral corticosteroids, which have been shown to improve rates of full recovery (number needed to treat = 10) and ...
  35. [35]
    Bell's Palsy: Diagnosis and Management - AAFP
    Oct 1, 2007 · Approximately 70 to 80 percent of patients will recover spontaneously; however, treatment with a seven-day course of acyclovir or valacyclovir ...Missing: sources | Show results with:sources
  36. [36]
    Recovery and Recurrence in Bell's Palsy: A Propensity Score ...
    Jul 9, 2025 · Although spontaneous recovery occurs in 70–85% of cases, timely intervention is critical to minimize long-term sequelae, particularly in ...Missing: sources | Show results with:sources
  37. [37]
    Bell's palsy - PMC - PubMed Central - NIH
    Most people with paresis make a spontaneous recovery within 3 weeks. Up to 30% of people, typically those with paralysis, have a delayed or incomplete recovery.Missing: annual | Show results with:annual
  38. [38]
    Erb Palsy - StatPearls - NCBI Bookshelf
    Apr 8, 2023 · Erb palsy, or Erb-Duchenne paralysis, is one of the most common neurological birth injuries. It is caused by injury to the brachial plexus, ...Continuing Education Activity · Introduction · Etiology · History and Physical
  39. [39]
    Current Concepts in Brachial Plexus Birth Injuries - PubMed Central
    Aug 22, 2024 · Upper trunk palsy (Erb palsy), seen in about 60% of cases, is characterized by the “waiter's tip” position due to deficits in muscles innervated ...
  40. [40]
    Klumpke Palsy - StatPearls - NCBI Bookshelf
    The main mechanism of injury to the lower brachial plexus is hyper-abduction traction, and depending on the intensity, it will lead to signs and symptoms ...
  41. [41]
    Simultaneous Erb's and Klumpke's palsy: Case report - PMC - NIH
    Klumpke's palsy or Dejerine-Klumpke palsy describes injury to the lower roots (C8, T1). These are usually brought about by a specific injury mechanism ...
  42. [42]
    Todd Paresis - StatPearls - NCBI Bookshelf - NIH
    Todd paresis, also known as Todd paralysis or Todd palsy, is a common syndrome associated with weakness or paralysis in part or all of the body after a seizure.Continuing Education Activity · Etiology · History and Physical · Evaluation
  43. [43]
    Frequency and Pathophysiology of Post-Seizure Todd's Paralysis
    Todd's paralysis, a neurological abnormality characterized by temporary limb weakness or hemiplegia, typically occurs following a seizure, without enduring ...
  44. [44]
    Clinical features of Todd's post-epileptic paralysis - PubMed
    Post-epileptic paralysis persisted from half an hour to 36 hours (mean of 15 hours). Post-epileptic paralysis may occur with the first seizure or after many ...
  45. [45]
    Motor Neuron Diseases | National Institute of Neurological Disorders ...
    Mar 26, 2025 · Progressive bulbar palsy (PBP), also known as progressive bulbar atrophy, is due to injury of the upper motor neurons in the brainstem or the ...What are motor neuron... · Who is more likely to have... · How are motor neuron...
  46. [46]
    Palliative Care Challenges of Patients With Progressive Bulbar Palsy
    Progressive bulbar palsy (PBP) is a form of motoneuron disease and is widely classified as a subtype of amyotrophic lateral sclerosis (ALS) with a shorter ...
  47. [47]
    Abducens Nerve Palsy as a Presenting Symptom of Multiple Sclerosis
    Our report details a patient with horizontal diplopia from an isolated abducens (sixth) nerve palsy as the initial symptom of MS.
  48. [48]
    Isolated peripheral facial nerve palsy in multiple sclerosis - PMC - NIH
    The incidence of peripheral facial nerve palsy in patients with multiple sclerosis is estimated at around 0.2%.
  49. [49]
    Guillain-Barre syndrome - Symptoms and causes - Mayo Clinic
    Jun 7, 2024 · Weakness and tingling in the hands and feet are usually the first symptoms. These sensations can quickly spread and may lead to paralysis. In ...
  50. [50]
    Guillain-Barre Syndrome Presenting With Bilateral Facial Nerve Palsy
    From 20 to 60% of patients with GBS develop facial palsy that is usually bilateral but mostly associated with limb weakness. Landry Guillain-Barre Syndrome ...
  51. [51]
    Recent developments in Bell's palsy - PMC - PubMed Central
    Bell's palsy causes a peripheral lower motor neurone palsy, which manifests as the unilateral impairment of movement in the facial and platysma muscles, ...
  52. [52]
    Alleviation of Motor Impairments in Patients with Cerebral Palsy
    Aug 16, 2017 · Individuals suffering from cerebral palsy (CP) often have involuntary, reflex-evoked muscle activity resulting in spastic hyperreflexia.
  53. [53]
    Cerebral palsy in children: a clinical overview - PMC - NIH
    Cerebral palsy (CP) is a disorder characterized by abnormal tone, posture and movement and clinically classified based on the predominant motor syndrome.Diagnosis · Prevention And Treatment... · Table 9. Orthopedic...<|separator|>
  54. [54]
    Facial Nerve Palsy - StatPearls - NCBI Bookshelf - NIH
    Facial Nerve Palsy in Children. The causes of facial nerve palsy in children classify as either congenital or acquired. Acquired causes are the same as in ...
  55. [55]
    Cerebral palsy - Symptoms and causes - Mayo Clinic
    Sep 28, 2023 · Cerebral palsy is a group of conditions that affect movement and posture. It's caused by damage that occurs to the developing brain, most often before birth.
  56. [56]
    Vision Impairment in children with Cerebral Palsy - Physiopedia
    One in every ten children with Cerebral Palsy (CP) presents with severe visual impairment and 75-90% present with some degree of visual impairment.<|separator|>
  57. [57]
  58. [58]
    Cerebral Palsy Statistics | Facts and Insights on CP
    Oct 29, 2025 · About 50% of children with cerebral palsy also have an intellectual disability. ... In wealthier countries, cerebral palsy prevalence is ...
  59. [59]
    Risk of Depression and Anxiety in Adults With Cerebral Palsy
    Dec 28, 2018 · Adults with cerebral palsy have a higher risk of developing anxiety and depression than adults who do not have cerebral palsy.
  60. [60]
    Chronic pain, fatigue, and depressive symptoms in adults ... - PubMed
    Jul 19, 2012 · Chronic pain and severe fatigue co-occurred in 34% and in combination with depressive symptoms in 16% of the participants. Severity of fatigue ...
  61. [61]
    The Pros and Cons of Operating Early Versus Late in the ...
    Scoliosis is the most common spinal deformity among individuals with cerebral palsy (CP) with an overall incidence of 20% to 25% and as high as 74% in ...
  62. [62]
    Cerebral palsy digestive issues and health
    May 28, 2025 · Children with cerebral palsy are at an increased risk for digestive issues, including upset stomach, vomiting, bloating, and constipation.Symptoms Of Digestion... · Gastrointestinal Conditions... · Treatment For Digestive...
  63. [63]
    Gastrointestinal motility disorders in neurologic disease - PMC
    Common gastrointestinal symptoms in neurologic disorders include sialorrhea, dysphagia, gastroparesis, intestinal pseudo-obstruction, constipation, diarrhea, ...
  64. [64]
    Weakness and paralysis - Knowledge @ AMBOSS
    May 12, 2025 · The approach to patients with weakness requires careful clinical evaluation, including a detailed history and physical examination focusing on ...
  65. [65]
    Modified Ashworth Scale - StatPearls - NCBI Bookshelf
    Apr 4, 2025 · The Modified Ashworth Scale (MAS) is the most widely used clinical tool for measuring increased muscle tone.[1] Spasticity was defined by Jim ...
  66. [66]
    Evaluation of the adult with acute weakness in the emergency ...
    Jul 15, 2025 · DIFFERENTIAL DIAGNOSIS OF ACUTE WEAKNESS Life-threatening medical causes with focal findings · Life-threatening causes of generalized weakness ...
  67. [67]
    Cerebral palsy - Diagnosis and treatment - Mayo Clinic
    Sep 28, 2023 · The health care professional also reviews your child's medical history, conducts a physical exam and monitors your child's growth and ...
  68. [68]
    A systematic review of neuroimaging for cerebral palsy - PubMed - NIH
    This article reviews the evidence provided by magnetic resonance imaging (MRI) and computed tomography (CT) imaging studies in cerebral palsy
  69. [69]
    MRCT and CT in the diagnosis of pediatric disease imaging - NIH
    Apr 25, 2024 · MRI is one of preventive and diagnostic techniques for cerebral palsy [8]. MRI plays a considerable role in the diagnosis of movement disorders, ...
  70. [70]
    Electromyography (EMG) - Mayo Clinic
    May 21, 2019 · A nerve conduction study, another part of an EMG, uses electrode stickers applied to the skin (surface electrodes) to measure the speed and ...
  71. [71]
    Electrodiagnostic Evaluation of Peripheral Neuropathy - NCBI - NIH
    Jan 30, 2023 · Electrodiagnostic testing, which includes nerve conduction studies (NCS) and needle electromyography (EMG), can support the diagnosis of peripheral neuropathy.Continuing Education Activity · Contraindications · Technique or Treatment
  72. [72]
    Bell's palsy - Diagnosis and treatment - Mayo Clinic
    Mar 15, 2024 · Blood tests.​​ There is no blood test for Bell's palsy. But blood tests can be used to rule out Lyme disease and other infections.
  73. [73]
    Laboratory Diagnosis of Lyme Disease - Advances and Challenges
    The majority of laboratory tests performed for the diagnosis of Lyme disease are based on detection of the antibody responses against B. burgdorferi in serum.Missing: disorders | Show results with:disorders
  74. [74]
    Lumbar puncture (spinal tap) - Mayo Clinic
    May 4, 2024 · A lumbar puncture, also known as a spinal tap, is a test used to diagnose certain health conditions. It's performed in your lower back, in the lumbar region.
  75. [75]
    Consensus guidelines for lumbar puncture in patients with ...
    May 18, 2017 · Cerebrospinal fluid collection by lumbar puncture (LP) is performed in the diagnostic workup of several neurological brain diseases.
  76. [76]
    Cerebral Palsy Genetics: Who to Test? - PMC - NIH
    Dec 1, 2022 · To determine which cerebral palsy (CP) patients should undergo genetic testing, we compared the rate of likely causative genetic variants ...
  77. [77]
    Invitae Cerebral Palsy Spectrum Disorders Panel | Test catalog
    The Invitae Cerebral Palsy Spectrum Disorders Panel analyzes a broad panel of genes to determine the underlying etiology of cerebral palsy (CP).
  78. [78]
    Evidence-based guideline update: Steroids and antivirals for Bell ...
    For patients with new-onset Bell palsy, antiviral agents in combination with steroids do not increase the probability of facial functional recovery by >7%.
  79. [79]
    Botulinum Toxin in the Management of Children with Cerebral Palsy
    Injection of the gastrocnemius or the gastrosoleus is the most common indication for BoNT-A therapy in children with CP [1–6]. This is for two main reasons.
  80. [80]
    Spasticity Management in Cerebral Palsy | Rady Children's Health
    Botulinum Toxin Injections: Such as Botox® and Dysport®, injected directly into spastic muscles to weaken them by blocking transmission between the nerve and ...
  81. [81]
    Facial Nerve Decompression for Bell's Palsy: An Endless Debate - NIH
    It is difficult to prove the surgical effects of facial nerve decompression on Bell's palsy because many factors can influence surgical outcomes.
  82. [82]
    Tendon transfers in cerebral palsy: art or science? - PubMed
    Tendon transfers in cerebral palsy are commonly described as a method to improve function in the upper limb. The field can be considered by some to be more of ...
  83. [83]
    Forearm Tendon Transfers - Norton Children's
    Forearm Tendon Transfers for Cerebral Palsy. Tendons can be moved from one part of the wrist to another to change the wrist position during rest or activity.
  84. [84]
    Superior cerebellar peduncle deep brain stimulation for cerebral ...
    May 24, 2024 · In this pilot trial, SCP DBS showed promise as a well-tolerated treatment for CP, improving dystonic symptoms, spasticity, quality of life, and functional ...<|separator|>
  85. [85]
    Deep brain stimulation for dystonia treatment in cerebral palsy
    This research highlights the potential of DBS in improving the lives of individuals with dystonic CP, providing hope for further refinement, innovation, and ...
  86. [86]
    Facial Nerve Decompression Surgery | FPI
    Facial nerve surgery is sometimes used to treat long-standing Bell's palsy and other types of facial paralysis. It alleviates pressure on the facial nerve, and ...
  87. [87]
    Tendon Transfer Principles - Hand - Orthobullets
    Jun 24, 2021 · Specific Transfers & Indications. Goal to regain. FROM: Donor tendon (working). TO: Recipient Tendon (deficient). Musculocutaneous nerve palsy.Missing: decompression | Show results with:decompression
  88. [88]
    Evaluation of stem/stromal cell transplantation safety and efficacy in ...
    Aug 29, 2025 · The findings suggest that stem cell transplantation was safe and effective for treating cerebral palsy. However, further high-quality RCTs with ...
  89. [89]
    Cerebral Palsy and Stem Cell Therapy
    May 27, 2025 · Stem cell therapy is a newer treatment for cerebral palsy. Early studies indicate that stem cell therapy could improve gross motor function in cerebral palsy.Missing: gene | Show results with:gene
  90. [90]
    The journey to a treatment for hereditary spastic paraplegia
    Oct 14, 2025 · Researchers and parents collaborate to find a possible solution for a rare form of hereditary spastic paraplegia.
  91. [91]
    Rehabilitative Therapies in Cerebral Palsy: The Good, the Not As ...
    In this article, we discuss the scientific evidence for various physical therapy treatment options for children with cerebral palsy.
  92. [92]
    Evidence-based Approach to Physical Therapy in Cerebral Palsy
    Moderate evidence of effectiveness was found for constraint-induced movement therapy for upper limb recovery, goal-directed/functional training, and gait ...
  93. [93]
    Occupational Therapy for Cerebral Palsy - Improve Daily Skills
    Jul 14, 2024 · Occupational therapy helps children with cerebral palsy gain independence by improving the skills needed for everyday activities.
  94. [94]
    Managing Speech and Swallowing Changes - The ALS Association
    Some of the “bulbar symptoms” of ALS include difficulty speaking or swallowing. Here are some tips on how to manage speaking and swallowing while living with ...
  95. [95]
    Understanding Bulbar Palsy: Symptoms, Causes, and Effective ...
    Aug 2, 2024 · Speech therapy is essential; it focuses on strengthening exercises for the muscles used in swallowing and speech production. Methods like ...
  96. [96]
    Communication Devices for Cerebral Palsy | Learn How They Can ...
    Apr 21, 2023 · AAC devices are some of the primary ways that many children with cerebral palsy communicate if they have speech or hearing impairments.
  97. [97]
    Efficacy of Lower Limb Orthoses in the Rehabilitation of Children ...
    Feb 6, 2024 · Lower limb orthoses are frequently used in children suffering from cerebral palsy (CP) alongside rehabilitation.
  98. [98]
    Orthotic management of cerebral palsy: recommendations ... - PubMed
    Substantial evidence suggests that ankle-foot orthoses (AFOs) that control the foot and ankle in stance and swing phases can improve gait efficiency in ...
  99. [99]
    Aquatic therapy for spastic cerebral palsy: a scoping review
    Nov 29, 2024 · As a specific treatment, aquatic therapy (AT) can improve spasticity, increase range of motion, and increase muscle strength due to its particular properties.
  100. [100]
    Mental Health Considerations With Cerebral Palsy - Physiopedia
    Individuals with cerebral palsy are at an increased risk of mental health conditions, such as anxiety, [2] depression and post-traumatic stress disorder (PTSD).
  101. [101]
    Recovery rate and prognostic factors of peripheral facial palsy ...
    Mar 18, 2025 · The recovery rate to HB Grade 1 was 75.1% after 1 year and reached 83.3% after 2 years. The median recovery time for HB Grade 1 was 72 days (IQR ...
  102. [102]
    Cerebral Palsy Life Expectancy | What It Means for My Child
    Oct 17, 2025 · Research shows that more than 80% of people with mild cerebral palsy live beyond age 58. Children with spastic quadriplegia and multiple ...
  103. [103]
    Efficacy of Early Intervention for Infants With Cerebral Palsy in an LMIC
    Mar 22, 2024 · Consistent with what is known about targeted training, children with ambulatory CP receiving LEAP-CP did, however, have better motor outcomes.
  104. [104]
    Early Intervention Service Use and Outcomes Among a Safety-Net ...
    Jan 25, 2019 · In this study, greater EI service intensity was associated with better functional gains, yet most children in the study received delayed care and/or low ...
  105. [105]
    Evaluation of prognostic factors in patients with Bell's palsy - PMC
    Sep 27, 2021 · Most of the patients with Bell's palsy have favorable outcomes. Age, hypertension, initial H‐B grade, and extent of facial nerve degeneration
  106. [106]
    Strengthening Equitable Access to Care and Support for Children ...
    Jun 1, 2023 · Also, in one study, increased satisfaction in care and navigating the chronicity of cerebral palsy was ranked higher among caregivers who had ...
  107. [107]
    Social Determinants of Health in Cerebral Palsy - PMC - NIH
    Nov 23, 2024 · As such, unmet social and mental health needs of caregivers may amplify health disparities and common precursors of CP (e.g., preterm birth, ...
  108. [108]
    Survival and mortality in cerebral palsy: observations to the sixth ...
    Jun 4, 2019 · For 22% of individuals with cerebral palsy with mild impairment survival to 58 years is similar to that of the general population.
  109. [109]
    Outcome in cerebral palsy: life-expectancy - ScienceDirect.com
    A 2 year old with severe CP has about a 40% chance of living to age 20, in contrast to a child with mild CP, for whom the chance is 99%.
  110. [110]
    Pain Phenotypes in Adults Living With Cerebral Palsy - PMC
    Adults with CP experience a vast array of chronic pain subtypes, spanning nociceptive pain, nociplastic pain, neuropathic pain, and a combination of neuropathic ...
  111. [111]
    Stroke-Induced Secondary Neurodegeneration of the Corticospinal ...
    Mar 28, 2024 · This last one is called secondary neurodegeneration, and it refers to the loss of substance and function in brain regions connected to the site ...
  112. [112]
    Psychosocial and Economic Burden on Families of Children With ...
    Jan 2, 2025 · The psychosocial impact on caregivers includes emotional stress, mental health challenges, disruption of social life, and a feeling of isolation ...
  113. [113]
    Physical inactivity and secondary health complications in cerebral ...
    Sep 5, 2014 · Individuals with cerebral palsy (CP) are at risk for various secondary health complications including orthopedic abnormalities, exaggerated sedentary ...
  114. [114]
    Global prevalence of cerebral palsy: A systematic analysis - PMC
    Aug 11, 2022 · Current overall CP birth prevalence for HICs is 1.6 per 1000 live births. Trends in low‐ and middle‐income countries (LMICs) cannot currently ...
  115. [115]
    Cerebral palsy - ScienceDirect.com
    Jul 18, 2025 · Cerebral palsy is a lifelong physical disability affecting movement and posture. The motor impairments of cerebral palsy result from non-degenerative brain ...
  116. [116]
    Bell's Palsy Epidemiology - News-Medical
    The majority of large population studies reveal a yearly incidence of 15-30 cases per 100.000 persons. The annual incidence of Bell's palsy in the United ...Missing: spontaneous recovery 70-85%
  117. [117]
    Cerebral Palsy Statistics, Facts, Prevalence & Demographics
    Males are slightly more likely to be diagnosed with cerebral palsy than females, at a ratio of about 1.4:1. In low- and middle-income countries, access to ...
  118. [118]
    Cerebral Palsy Statistics - Mastermind Behavior Services
    Mar 3, 2025 · In high-income countries, the birth prevalence is typically estimated at 1.5 per 1,000 live births, while in low- and middle-income countries, ...
  119. [119]
    Racial, Ethnic, and Socioeconomic Disparities in the Prevalence of ...
    Black infants have an increased risk of cerebral palsy when compared with white infants. The reason for this racial disparity is unclear.
  120. [120]
    Bell's Palsy - American Brain Foundation
    While Bell's palsy can affect people of any age, it has the highest incidence among people who are 15 to 45 years old. It affects men and women equally. Risk ...
  121. [121]
    Increased risk of Bell palsy in patient with migraine - Medicine
    Approximately 11 to 40 people per 100,000 experience Bell palsy worldwide each year. The incidence of Bell palsy peaks in middle age and has no gender ...
  122. [122]
    Sustained decline in rate and severity of cerebral palsy ...
    Analysing data from almost 11,000 children with cerebral palsy (CP) in every state and territory, researchers found that the rate of CP has fallen to 1.5/1,000 ...
  123. [123]
    Risk Factors Associated With Bell's Palsy: A Real‐World Analysis of ...
    Aug 21, 2025 · Its etiology remains largely unknown, though risk factors such as herpes simplex virus reactivation, diabetes, depression, and pregnancy‐related ...
  124. [124]
    Immunization coverage - World Health Organization (WHO)
    Jul 15, 2025 · Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF 15 July 2025. More.
  125. [125]
    Global childhood vaccination holds steady, yet over 14 million ...
    GENEVA/NEW YORK, 15 July 2025 – In 2024, 89 per cent of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and ...<|control11|><|separator|>
  126. [126]
    Palsy - Etymology, Origin & Meaning
    Originating c. 1300 from Greek paralysis meaning "loosening," this word denotes weakness, numbness, or loss of bodily function, evolving through Latin and ...
  127. [127]
    Apoplexy, cerebrovascular disease, and stroke: Historical evolution ...
    Hippocrates (and the Hippocratic Corpus) is responsible for the first recorded appearance of the term “apoplexy”. The concept is mentioned in several parts of ...
  128. [128]
    The Hippocratic Doctrine of “the Acute Brain Suffering” as the Brain ...
    Background: The ancient Greek term "apoplexy" as is repeatedly mentioned by the Hippocratic School of Medicine, included a cluster of diseases, mainly those ...
  129. [129]
    Historic review: select chapters of a history of stroke
    Dec 1, 2020 · In Homeric Greek, some four centuries before Hippocratic physicians appeared on the scene, stroke meant “plex” or “plexy” and god meant “theos” ...
  130. [130]
    William John Little (1810–1894) - PMC - NIH
    Sep 4, 2015 · Little believed that cerebral palsy resulted from post-partum asphyxia, which distorted the blood flow and in this way damaged the child's brain ...
  131. [131]
    The history of facial palsy and spasm: Hippocrates to Razi - PMC
    Jul 12, 2011 · In this article, we describe the history of facial distortion by Greek, Roman, and Persian physicians, culminating in Razi's detailed description in al-Hawi.
  132. [132]
    Sir Charles Bell (1774−1842): contributions to neuro‐ophthalmology
    Aug 7, 2007 · The latter is now recognized as an often idiopathic, but characteristically peripheral, lower motor neuron facial palsy. Its manifestations are ...
  133. [133]
    MRI Findings in Two Cases of Acute Facial Paralysis - Labagnara
    This article describes the use of magnetic resonance imaging (MRI) in the evaluation of the facial nerve paralysis of Bell's palsy and herpes zoster oticus.
  134. [134]
    Rethinking Cerebral Palsy Origins | Harvard Medical School
    Jan 28, 2022 · A first-of-its-kind study by Srivastava and colleagues has found that up to 1 in 4 patients with CP have an underlying genetic condition.
  135. [135]
    Cerebral palsy as a childhood-onset neurological disorder caused ...
    Recent genetic studies have identified a diagnostic yield of 28–31 % in CP cases, with the majority attributed to single nucleotide variants (∼25 %) and a ...